FNIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.447800E-01
Normal-vs-Stage2
5.924400E-01
Normal-vs-Stage3
1.848190E-02
Normal-vs-Stage4
9.039800E-01
Stage1-vs-Stage2
8.055800E-01
Stage1-vs-Stage3
6.463700E-02
Stage1-vs-Stage4
8.481200E-01
Stage2-vs-Stage3
4.862300E-02
Stage2-vs-Stage4
6.546200E-01
Stage3-vs-Stage4
6.469900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.377600E-01
Normal-vs-AfricanAmerican
9.956200E-01
Normal-vs-Asian
5.077200E-01
Caucasian-vs-AfricanAmerican
3.890400E-01
Caucasian-vs-Asian
6.700200E-01
AfricanAmerican-vs-Asian
4.348800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.638400E-01
Normal-vs-Female
5.101600E-01
Male-vs-Female
4.817000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.997800E-01
Normal-vs-Age(41-60Yrs)
9.023400E-01
Normal-vs-Age(61-80Yrs)
3.980800E-01
Normal-vs-Age(81-100Yrs)
1.672790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.029000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.005800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.905560E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.965400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.146340E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.597000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.234200E-01
Normal-vs-Daily Drinker
2.575200E-01
Normal-vs-Weekly Drinker
4.936200E-01
Normal-vs-Occasional Drinker
8.285400E-01
Normal-vs-Social Drinker
9.363800E-01
Non Drinker-vs-Daily Drinker
7.718200E-01
Non Drinker-vs-Weekly Drinker
9.184000E-01
Non Drinker-vs-Occasional Drinker
2.391600E-01
Non Drinker-vs-Social Drinker
1.746390E-01
Daily Drinker-vs-Weekly Drinker
7.242600E-01
Daily Drinker-vs-Occasional Drinker
1.316980E-01
Daily Drinker-vs-Social Drinker
8.789800E-02
Weekly Drinker-vs-Occasional Drinker
3.794000E-01
Weekly Drinker-vs-Social Drinker
2.948400E-01
Occasional Drinker-vs-Social Drinker
8.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.770500E-02
Normal-vs-Grade 2
2.640100E-03
Normal-vs-Grade 3
6.280800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.343000E-01
Grade 1-vs-Grade 3
1.278820E-01
Grade 1-vs-Grade 4
6.770500E-02
Grade 2-vs-Grade 3
3.342200E-01
Grade 2-vs-Grade 4
2.640100E-03
Grade 3-vs-Grade 4
6.280800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.616800E-01
Normal-vs-NonDiabetic
5.880600E-01
Diabetic-vs-NonDiabetic
2.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.486600E-01
Normal-vs-NoPancreatitis
5.759000E-01
Pancreatitis-vs-NoPancreatitis
4.255200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.879000E-01
Normal-vs-N1
5.865800E-01
N0-vs-N1
8.814200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.962200E-01
Normal-vs-TP53-NonMutant
6.282600E-01
TP53-Mutant-vs-TP53-NonMutant
9.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
